Ariadna Giró‐Perafita

Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer

Ariadna Giró‐Perafita, Sònia Palomeras, David H. Lum et al. · Clinical Cancer Research · 2016 · 88 citations · Full text

Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process

Alireza Khodadadi‐Jamayran, Betul Akgol-Oksuz, Yelena Afanasyeva et al. · Oncotarget · 2018 · 62 citations · Full text

Prognostic Biomarkers, Breast Oncology, Medicine +15

Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs

Adriana Blancafort, Ariadna Giró‐Perafita, Glòria Oliveras et al. · PLoS ONE · 2015 · 60 citations · Full text

Breast Oncology, Anti-her2 Drugs, Endocrine-related Cancer +15

Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer

Ariadna Giró‐Perafita, Ariadna Sarrats, Ferran Pérez-Bueno et al. · Oncotarget · 2017 · 48 citations · Full text

LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer

Ariadna Giró‐Perafita, L Q Luo, Alireza Khodadadi‐Jamayran et al. · npj Breast Cancer · 2020 · 33 citations · Full text